Negative or defect symptoms refer to a reduction in normal functioning. In
schizophrenia, negative symptoms encompass, among others, anhedonia, flat a
ffect, avolition and social withdrawal. These symptoms have been found to b
e particularly prominent in the more chronic phase of the illness and seem
to be virtually insensitive to current antipsychotic treatment. This review
focuses on the possibilities and limitations of animal models for the nega
tive symptoms of schizophrenia. Following a review of the negative symptoms
in schizophrenia, attention is focused on the two symptoms most often mode
lled in animals - anhedonia and social withdrawal. We then look at the impo
rtant question of how to model schizophrenic pathology in animals. Since th
e exact pathology is still far from clear, most efforts have in the past co
ncentrated on using psychotomimetic drugs such as amphetamine or phencyclid
ine. The recently accumulated knowledge that schizophrenia probably results
from disturbances in the normal development of the brain has led to a surg
e of new animal models in which the long-term consequences of early manipul
ations are investigated. However, so far these models have predominantly co
ncentrated on the positive rather than the negative symptoms of schizophren
ia. The last part of this review is dedicated to the question of validation
of animal models for anhedonia and social withdrawal. The general conclusi
on is that very few models have so far been adequately tested. The lack of
currently effective treatment further hampers the study of such validation.
(C) 2000 Lippincott Williams & Wilkins.